YP-1400 Laboratory Single-Station Tablet Press

Overview

The YP-1400 Laboratory Single-Station Tablet Press is a compact, self-contained electromechanical compression system engineered for precision formulation development and small-batch tablet manufacturing in regulated R&D and QC environments. Operating on the principle of uniaxial mechanical compression—where an upper punch applies controlled force to powder within a die cavity against a stationary lower punch—the YP-1400 delivers reproducible tablet geometry, thickness, and hardness under programmable speed and pressure parameters. Designed to ISO 8573-1 clean air compatibility standards and constructed to meet fundamental GMP design criteria per Annex 15 (EU GMP) and USP , this press supports early-phase dosage form screening, excipient compatibility testing, and pilot-scale batch replication without requiring external utilities or structural anchoring. Its tabletop footprint and integrated drive motor eliminate dependency on compressed air or hydraulic systems, enabling deployment in ISO Class 7 clean benches, university labs, and contract development laboratories where space and infrastructure are constrained.

Key Features

• Fully automatic operation with stepless speed regulation (10–140 tablets per minute), enabling precise control over dwell time and compression profile consistency.
• Interchangeable punch sets accommodating tablet diameters from 3 mm to 20 mm—compatible with standard TSM and EU-standard tooling geometries.
• Dual-material construction: main frame fabricated from AISI 304 stainless steel; all product-contact surfaces—including die bore, upper/lower punches, and feeder shoe—made from corrosion-resistant AISI 316 stainless steel (EN 1.4401), passivated per ASTM A967.
• Integrated jog-and-reverse function allows manual advancement or controlled retraction of the upper punch during setup, tooling alignment, or jam resolution—minimizing downtime and material waste during method development.
• Modular hopper interface supports optional volumetric feeders or gravity-fed extensions for improved flow uniformity with low-density or cohesive powders.
• Standalone electrical architecture: single-phase 220–240 V AC input, 1.2 kW induction motor with thermal overload protection—certified to IEC 60335-1 and CE-marked for safe laboratory use.

Sample Compatibility & Compliance

The YP-1400 accommodates free-flowing and moderately cohesive pharmaceutical powders, herbal granules, nutraceutical blends, and ceramic precursors—provided bulk density exceeds 0.4 g/cm³ and Carr’s Index remains below 25%. It supports direct compression, dry granulation (slugging), and pre-compression workflows when paired with compatible milling or blending equipment. All wetted components comply with USP Class VI biocompatibility requirements. The unit is designed to support audit-ready documentation per FDA 21 CFR Part 11 when integrated with validated electronic logbook systems (e.g., LabVantage, Empower). While not certified as a full GMP production asset, its materials-of-construction, surface finish (Ra ≤ 0.8 µm on contact surfaces), and traceable assembly process align with WHO TRS 986 Annex 2 and PIC/S PE 009-16 expectations for laboratory-scale equipment used in registration batches.

Software & Data Management

The YP-1400 operates via embedded microcontroller logic with LED-based parameter display and tactile push-button interface—no proprietary software or PC connection required. Process parameters (speed, run duration, total count) are logged internally with timestamping and retained across power cycles. For traceability integration, analog 0–10 V and digital pulse outputs are provided for connection to external SCADA, LIMS, or MES platforms. Optional RS-485 Modbus RTU communication enables remote monitoring of cycle status, motor load feedback, and fault codes—facilitating alignment with Industry 4.0 lab infrastructure and supporting GLP-compliant audit trails when paired with qualified data acquisition systems.

Applications

• Pre-formulation studies: evaluation of compressibility, tabletability, and capping tendency across API-excipient matrices.
• GMP-aligned analytical reference standard preparation—especially for dissolution testing and content uniformity validation.
• Taste-masking development: rapid prototyping of coated or layered tablets for sensory assessment panels.
• Veterinary and agrochemical solid-dose development: compression of microgranules, bait tablets, and slow-release formulations.
• Academic research: teaching compression physics, powder rheology correlation, and mechanical property mapping (hardness vs. ejection force).
• Medical device component fabrication: sinterable metal or polymer compacts for subsequent thermal processing.

FAQ

Is the YP-1400 compliant with current GMP requirements for clinical trial material manufacturing?
It meets foundational GMP design principles for laboratory-scale equipment (e.g., cleanability, material traceability, absence of shedding parts) but requires site-specific qualification (IQ/OQ/PQ) and procedural controls to support GMP batch release.
Can custom tooling be supplied for non-circular tablet shapes?
Yes—custom punches and dies for oval, capsule-shaped, triangular, or scored tablets can be manufactured to ISO 8738 specifications upon provision of dimensional drawings and material certification requirements.
What maintenance intervals are recommended for sustained accuracy?
Lubrication of cam tracks and punch guides every 50 operational hours; annual calibration of force transducer (if equipped) and verification of punch alignment using optical comparator or coordinate measuring machine (CMM).
Does the press support weight variation monitoring during operation?
No real-time weight measurement is built-in; however, the consistent dwell time and fill-depth repeatability enable statistical process control when paired with off-line check-weighing per USP .
Is technical support available outside mainland China?
Yes—authorized service partners provide on-site commissioning, preventive maintenance, and spare parts logistics across APAC, EMEA, and North America under contractual service level agreements (SLAs).